These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11573306)

  • 1. Multidrug-resistant tuberculosis.
    Wkly Epidemiol Rec; 2001 Sep; 76(36):273. PubMed ID: 11573306
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant tuberculosis: desperate measures?
    Cullinan T
    Lancet; 2001 Apr; 357(9262):1124. PubMed ID: 11297986
    [No Abstract]   [Full Text] [Related]  

  • 3. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Treatment Cost on Transmission of Multidrug-Resistant Tuberculosis Into Iran.
    Bialvaei AZ; Kafil HS; Asgharzadeh M
    Clin Infect Dis; 2015 Sep; 61(6):1029-30. PubMed ID: 26060290
    [No Abstract]   [Full Text] [Related]  

  • 6. Time to put boots on the ground: making universal access to MDR-TB treatment a reality.
    Keshavjee S; Farmer PE
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1222-5. PubMed ID: 20843411
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: the treatment of multi-drug resistant tuberculosis--a return to the pre-antibiotic era?
    Ollé-Goig JE
    Trop Med Int Health; 2006 Nov; 11(11):1625-8. PubMed ID: 17054741
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to drug resistant tuberculosis is insufficient and too slow.
    Cui W
    BMJ; 2011 Mar; 342():d1969. PubMed ID: 21444638
    [No Abstract]   [Full Text] [Related]  

  • 9. TB drug prices slashed for poor countries.
    Hagmann M
    Bull World Health Organ; 2001; 79(9):904-5. PubMed ID: 11584747
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology of multidrug-resistant tuberculosis.
    Ortona L; De Luca A
    Rays; 1998; 23(1):15-8. PubMed ID: 9673129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 12. Programmatic management of multidrug resistant TB.
    Sarin R
    Indian J Tuberc; 2009 Oct; 56(4):171-3. PubMed ID: 20469727
    [No Abstract]   [Full Text] [Related]  

  • 13. Multidrug resistant tuberculous meningitis in the United States, 1993-2005.
    Vinnard C; Winston CA; Wileyto EP; MacGregor RR; Bisson GP
    J Infect; 2011 Sep; 63(3):240-2. PubMed ID: 21784099
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area.
    van der Werf MJ; Sandgren A; Manissero D
    Int J Tuberc Lung Dis; 2012; 16(3):426. PubMed ID: 22640458
    [No Abstract]   [Full Text] [Related]  

  • 15. Curing multidrug-resistant tuberculosis: not all about the money.
    Gruber K
    Lancet Respir Med; 2016 Nov; 4(11):870-871. PubMed ID: 27799128
    [No Abstract]   [Full Text] [Related]  

  • 16. Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility.
    Lunte K; Cordier-Lassalle T; Keravec J
    Bull World Health Organ; 2015 Apr; 93(4):279-82. PubMed ID: 26229192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myanmar grapples with its high tuberculosis burden.
    Cousins S
    Lancet; 2017 Feb; 389(10068):491-492. PubMed ID: 28170324
    [No Abstract]   [Full Text] [Related]  

  • 18. Limited access to drugs for resistant tuberculosis: a call to action.
    Bélard S; Janssen S; Osbak KK; Adegnika AA; Ondounda M; Grobusch MP
    J Public Health (Oxf); 2015 Dec; 37(4):691-3. PubMed ID: 25527468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The major infectious diseases in the world--to treat or not to treat?
    Farmer P
    N Engl J Med; 2001 Jul; 345(3):208-10. PubMed ID: 11463018
    [No Abstract]   [Full Text] [Related]  

  • 20. [Concerning tuberculosis].
    Sante; 2000; 10(5):362-3. PubMed ID: 11221699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.